Iatrogenic atrial septal defect persistence after percutaneous mitral valve repair: a meta-analysis. 2022

Oliver Maier, and Katharina Hellhammer, and Patrick Horn, and Shazia Afzal, and Christian Jung, and Ralf Westenfeld, and Tobias Zeus, and Malte Kelm, and Verena Veulemans
Department of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.

BACKGROUND Percutaneous mitral valve repair (PMVR) requires a puncture of the atrial septum, resulting in iatrogenic atrial septal defect (iASD), which usually causes a transient left-to-right shunt. However, the influencing risk factors for iASD persistence and functional consequences are not fully understood. This meta-analysis aimed to summarise available data on the persistence of iASD following PMVR. METHODS The authors conducted a literature search in PubMed/MEDLINE and EMBASE databases to identify studies investigating iASD persistence in PMVR patients. RESULTS Six observational studies (n = 361) met inclusion criteria for the final analysis. Prevalence of persistent iASD was documented with 28% after 12 months follow-up. iASD size increased over time with a diameter of 5.3 ± 0.76 mm after one month and 6.5 ± 0.21 mm after 12 months. Possible predictors of iASD persistence after PMVR appeared to be pre-existing AF (RR 1.24; p = .03), residual mitral regurgitation > II° (RR 2.06; p = .03) and prolonged fluoroscopic time (RR 8.27; p = .01). Patients with iASD persistence had a higher risk for development of right heart overload regarding the increased area of the right atrium (MD 5.24; p = .004) and enlarged diameter of the right ventricle (MD 3.33; p < .0001). Rehospitalization was more frequently reported in iASD patients (RR 9.52; p = .004). CONCLUSIONS This meta-analysis proved iASD persistence in 28% of PMVR after 12 months follow-up with a higher risk for right heart volume overload and more frequent rehospitalization compared to patients without iASD persistence. Since percutaneous catheter-based treatments with transseptal approaches are rising, further evidence about the hemodynamic impact of persistent iASD is warranted.

UI MeSH Term Description Entries
D007049 Iatrogenic Disease Any adverse condition in a patient occurring as the result of treatment by a physician, surgeon, or other health professional, especially infections acquired by a patient during the course of treatment. Hospital-Acquired Condition,Condition, Hospital-Acquired,Conditions, Hospital-Acquired,Disease, Iatrogenic,Diseases, Iatrogenic,Hospital Acquired Condition,Hospital-Acquired Conditions,Iatrogenic Diseases
D008943 Mitral Valve The valve between the left atrium and left ventricle of the heart. Bicuspid Valve,Bicuspid Valves,Mitral Valves,Valve, Bicuspid,Valve, Mitral,Valves, Bicuspid,Valves, Mitral
D008944 Mitral Valve Insufficiency Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation. Mitral Incompetence,Mitral Regurgitation,Mitral Valve Incompetence,Mitral Insufficiency,Mitral Valve Regurgitation,Incompetence, Mitral,Incompetence, Mitral Valve,Insufficiency, Mitral,Insufficiency, Mitral Valve,Regurgitation, Mitral,Regurgitation, Mitral Valve,Valve Incompetence, Mitral,Valve Insufficiency, Mitral,Valve Regurgitation, Mitral
D006328 Cardiac Catheterization Procedures in which placement of CARDIAC CATHETERS is performed for therapeutic or diagnostic procedures. Catheterization, Cardiac,Catheterization, Heart,Heart Catheterization,Cardiac Catheterizations,Catheterizations, Cardiac,Catheterizations, Heart,Heart Catheterizations
D006344 Heart Septal Defects, Atrial Developmental abnormalities in any portion of the ATRIAL SEPTUM resulting in abnormal communications between the two upper chambers of the heart. Classification of atrial septal defects is based on location of the communication and types of incomplete fusion of atrial septa with the ENDOCARDIAL CUSHIONS in the fetal heart. They include ostium primum, ostium secundum, sinus venosus, and coronary sinus defects. Atrial Septal Defects,Ostium Primum Atrial Septal Defect,Persistent Ostium Primum,Atrial Septal Defect,Atrial Septal Defect Ostium Primum,Ostium Secundum Atrial Septal Defect,Defect, Atrial Septal,Ostium Primum, Persistent,Primum, Persistent Ostium,Septal Defect, Atrial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Oliver Maier, and Katharina Hellhammer, and Patrick Horn, and Shazia Afzal, and Christian Jung, and Ralf Westenfeld, and Tobias Zeus, and Malte Kelm, and Verena Veulemans
February 2018, The American journal of cardiology,
Oliver Maier, and Katharina Hellhammer, and Patrick Horn, and Shazia Afzal, and Christian Jung, and Ralf Westenfeld, and Tobias Zeus, and Malte Kelm, and Verena Veulemans
June 2021, Scientific reports,
Oliver Maier, and Katharina Hellhammer, and Patrick Horn, and Shazia Afzal, and Christian Jung, and Ralf Westenfeld, and Tobias Zeus, and Malte Kelm, and Verena Veulemans
January 1976, Acta clinica Belgica,
Oliver Maier, and Katharina Hellhammer, and Patrick Horn, and Shazia Afzal, and Christian Jung, and Ralf Westenfeld, and Tobias Zeus, and Malte Kelm, and Verena Veulemans
September 2016, Cardiovascular revascularization medicine : including molecular interventions,
Oliver Maier, and Katharina Hellhammer, and Patrick Horn, and Shazia Afzal, and Christian Jung, and Ralf Westenfeld, and Tobias Zeus, and Malte Kelm, and Verena Veulemans
November 2020, The Journal of invasive cardiology,
Oliver Maier, and Katharina Hellhammer, and Patrick Horn, and Shazia Afzal, and Christian Jung, and Ralf Westenfeld, and Tobias Zeus, and Malte Kelm, and Verena Veulemans
March 2015, JACC. Cardiovascular interventions,
Oliver Maier, and Katharina Hellhammer, and Patrick Horn, and Shazia Afzal, and Christian Jung, and Ralf Westenfeld, and Tobias Zeus, and Malte Kelm, and Verena Veulemans
October 2022, Circulation journal : official journal of the Japanese Circulation Society,
Oliver Maier, and Katharina Hellhammer, and Patrick Horn, and Shazia Afzal, and Christian Jung, and Ralf Westenfeld, and Tobias Zeus, and Malte Kelm, and Verena Veulemans
December 2020, JACC. Cardiovascular interventions,
Oliver Maier, and Katharina Hellhammer, and Patrick Horn, and Shazia Afzal, and Christian Jung, and Ralf Westenfeld, and Tobias Zeus, and Malte Kelm, and Verena Veulemans
December 2018, Cardiovascular revascularization medicine : including molecular interventions,
Oliver Maier, and Katharina Hellhammer, and Patrick Horn, and Shazia Afzal, and Christian Jung, and Ralf Westenfeld, and Tobias Zeus, and Malte Kelm, and Verena Veulemans
January 2021, Circulation,
Copied contents to your clipboard!